ⓘ Flotetuzumab

                                     

ⓘ Flotetuzumab

Flotetuzumab is a bispecific antibody designed for the treatment of acute myeloid leukemia.

This drug is developed by MacroGenics, Inc. in

                                     
  • glycoprotein 75 melanoma Fletikumab mab human IL 20 Rheumatoid arthritis Flotetuzumab di - scFv humanized IL 3 receptor hematological malignancies Fontolizumab